Cargando…

Discovery of Novel Integrase Inhibitors Acting outside the Active Site Through High-Throughput Screening

Currently, an increasing number of drugs are becoming available to clinics for the treatment of HIV infection. Even if this targeted therapy is highly effective at suppressing viral replication, caregivers are facing growing therapeutic failures in patients, due to resistance with or without treatme...

Descripción completa

Detalles Bibliográficos
Autores principales:	Aknin, Cindy, Smith, Elena A., Marchand, Christophe, Andreola, Marie-Line, Pommier, Yves, Metifiot, Mathieu
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2019
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6832134/ https://www.ncbi.nlm.nih.gov/pubmed/31614773 http://dx.doi.org/10.3390/molecules24203675

Ejemplares similares

Resistance to Integrase Inhibitors
por: Métifiot, Mathieu, et al.
Publicado: (2010)

De novo RNA synthesis catalyzed by the Zika Virus RNA polymerase domain
por: Calmels, Christina, et al.
Publicado: (2017)

HIV-1 Integrase Strand Transfer Inhibitors with Reduced Susceptibility to Drug Resistant Mutant Integrases
por: Zhao, Xue Zhi, et al.
Publicado: (2016)

Selectivity for strand-transfer over 3′-processing and susceptibility to clinical resistance of HIV-1 integrase inhibitors are driven by key enzyme–DNA interactions in the active site
por: Métifiot, Mathieu, et al.
Publicado: (2016)

Bicyclic 1-Hydroxy-2-oxo-1,2-dihydropyridine-3-carboxamide-Containing HIV-1 Integrase Inhibitors Having High Antiviral Potency against Cells Harboring Raltegravir-Resistant Integrase Mutants
por: Zhao, Xue Zhi, et al.
Publicado: (2014)

Structure-Guided Optimization of HIV Integrase Strand Transfer Inhibitors
por: Zhao, Xue Zhi, et al.
Publicado: (2017)

HIV-1 Integrase-Targeted Short Peptides Derived from a Viral Protein R Sequence
por: Zhao, Xue Zhi, et al.
Publicado: (2018)

4-Amino-1-hydroxy-2-oxo-1,8-naphthyridine-Containing Compounds Having High Potency against Raltegravir-Resistant Integrase Mutants of HIV-1
por: Zhao, Xue Zhi, et al.
Publicado: (2014)

Correction to 4-Amino-1-hydroxy-2-oxo-1,8-naphthyridine-Containing Compounds Having High Potency against Raltegravir-Resistant Integrase Mutants of HIV-1
por: Zhao, Xue Zhi, et al.
Publicado: (2014)

Absence of Resistance Mutations in the Integrase Coding Region among ART-Experienced Patients in the Republic of the Congo
por: Got, Ferdinand Emaniel Brel, et al.
Publicado: (2021)

Investigation of anti-HIV activity, cytotoxicity and HIV integrase inhibitory activity of polyherbal formulation BH extracts
por: Balraj, S, et al.
Publicado: (2014)

In vitro initial attachment of HIV-1 integrase to viral ends: control of the DNA specific interaction by the oligomerization state
por: Lesbats, P., et al.
Publicado: (2008)

G-quadruplexes in viruses: function and potential therapeutic applications
por: Métifiot, Mathieu, et al.
Publicado: (2014)

Basic Quinolinonyl Diketo Acid Derivatives as Inhibitors of HIV Integrase and their Activity against RNase H Function of Reverse Transcriptase
por: Costi, Roberta, et al.
Publicado: (2014)

Mutations Located outside the Integrase Gene Can Confer Resistance to HIV-1 Integrase Strand Transfer Inhibitors
por: Malet, Isabelle, et al.
Publicado: (2017)

Targeting the Integrated Stress Response Kinase GCN2 to Modulate Retroviral Integration
por: Torres, Chloé, et al.
Publicado: (2021)

GCN2 phosphorylates HIV-1 integrase and decreases HIV-1 replication by limiting viral integration
por: Jaspart, A., et al.
Publicado: (2017)

Discovery of small-molecule HIV-1 fusion and integrase inhibitors oleuropein and hydroxytyrosol: Part I. Integrase inhibition
por: Lee-Huang, Sylvia, et al.
Publicado: (2007)

Modulation of the intrinsic chromatin binding property of HIV-1 integrase by LEDGF/p75
por: Lapaillerie, Delphine, et al.
Publicado: (2021)

Novel Quinolinonyl Diketo Acid Derivatives as HIV-1 Integrase Inhibitors: Design, Synthesis, and Biological Activities
por: Di Santo, Roberto, et al.
Publicado: (2008)

Resistance Mutations outside the Integrase Coding Region Have an Effect on Human Immunodeficiency Virus Replicative Fitness but Do Not Affect Its Susceptibility to Integrase Strand Transfer Inhibitors
por: Weber, Jan, et al.
Publicado: (2013)

The HIV-1 Integrase Mutations Y143C/R Are an Alternative Pathway for Resistance to Raltegravir and Impact the Enzyme Functions
por: Reigadas, Sandrine, et al.
Publicado: (2010)

Novel high-throughput electrochemiluminescent assay for identification of human tyrosyl-DNA phosphodiesterase (Tdp1) inhibitors and characterization of furamidine (NSC 305831) as an inhibitor of Tdp1
por: Antony, Smitha, et al.
Publicado: (2007)

Recent advances in the discovery of small-molecule inhibitors of HIV-1 integrase
por: Choi, Eungi, et al.
Publicado: (2018)

Characterization of natural polymorphic sites of the HIV-1 integrase before the introduction of HIV-1 integrase inhibitors in Germany
por: Meixenberger, Karolin, et al.
Publicado: (2014)

Functional Coupling between HIV-1 Integrase and the SWI/SNF Chromatin Remodeling Complex for Efficient in vitro Integration into Stable Nucleosomes
por: Lesbats, Paul, et al.
Publicado: (2011)

Rapid Screening of HIV Reverse Transcriptase and Integrase Inhibitors
por: Smith, Steven J., et al.
Publicado: (2014)

High-Throughput Screening for Biomarker Discovery
por: Janvilisri, Tavan, et al.
Publicado: (2015)

Novel 3′-Processing Integrase Activity Assay by Real-Time PCR for Screening and Identification of HIV-1 Integrase Inhibitors
por: Sakkhachornphop, Supachai, et al.
Publicado: (2015)

High-Throughput Screening of Biodiversity for Antibiotic Discovery
por: Terekhov, S. S., et al.
Publicado: (2018)

Small Molecule Inhibitors of the LEDGF Site of Human Immunodeficiency Virus Integrase Identified by Fragment Screening and Structure Based Design
por: Peat, Thomas S., et al.
Publicado: (2012)

Attachment site recognition and regulation of directionality by the serine integrases
por: Rutherford, Karen, et al.
Publicado: (2013)

Relationship between HIV integrase polymorphisms and integrase inhibitor susceptibility: An in silico analysis
por: Hutapea, Hotma Martogi Lorensi, et al.
Publicado: (2018)

Cellular Cofactors of Lentiviral Integrase: From Target Validation to Drug Discovery
por: Taltynov, Oliver, et al.
Publicado: (2012)

Correction: Small Molecule Inhibitors of the LEDGF Site of Human Immunodeficiency Virus Integrase Identified by Fragment Screening and Structure Based Design
por: Peat, Thomas S., et al.
Publicado: (2013)

Discovery of Mcl-1 inhibitors from integrated high throughput and virtual screening
por: Mady, Ahmed S. A., et al.
Publicado: (2018)

A highly potent and safe pyrrolopyridine-based allosteric HIV-1 integrase inhibitor targeting host LEDGF/p75-integrase interaction site
por: Maehigashi, Tatsuya, et al.
Publicado: (2021)

Adaptation of High-Throughput Screening in Drug Discovery—Toxicological Screening Tests
por: Szymański, Paweł, et al.
Publicado: (2011)

Design of inhibitors of the HIV-1 integrase core domain using virtual screening
por: Regon, Preetom, et al.
Publicado: (2014)

HIV-2 Integrase Variation in Integrase Inhibitor-Naïve Adults in Senegal, West Africa
por: Gottlieb, Geoffrey S., et al.
Publicado: (2011)

Cannot write session to /tmp/vufind_sessions/sess_3jhsd8ojq9cqikpu22so7vk1oe